Company intelligence
Ataraxis AI
Transforming Cancer Care with AI Precision Medicine
About Ataraxis AI
Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard of care genomic assays. To learn more, visit ataraxis.ai.
Verified activity
Signals from Ataraxis AI
7 published signals
Research & Knowledge
Ataraxis AI is launching Ataraxis ARC, a prospective study designed to evaluate AI model predictions and link them with real-world cancer patient outcomes, with initial enrollment of 1,000 patients across top cancer centers.
Reported by Ataraxis AI
Research & Knowledge
Ataraxis AI is launching Ataraxis ARC, a prospective study designed to evaluate AI model predictions and link them with real-world cancer patient outcomes, with initial enrollment of 1,000 patients across top cancer centers.
Reported by Ataraxis AI
Research & Knowledge
Ataraxis AI is launching a prospective registry study evaluating its AI prediction in more than just breast cancer.
Reported by Mike Rocks
Research & Knowledge
Ataraxis AI launched Ataraxis ARC, a large prospective study evaluating how clinical AI helps build truly personalized treatment plans and impacts outcomes for real patients.
Reported by Jennifer Person, DBA
Research & Knowledge
Ataraxis AI highlighted that surgeons at London’s National Hospital for Neurology and Neurosurgery (UCLH) performed the world’s first live AI-assisted brain tumor operation in May.
Reported by Jennifer Person, DBA
Partnerships
Ataraxis AI joined the Lobular American Research Consortium, the first national, investigator-led consortium in the U.S. dedicated exclusively to invasive lobular carcinoma (ILC).
Reported by Ataraxis AI
Research & Knowledge
Ataraxis AI built a 5,000-patient model specifically for lobular cancer.
Reported by Mike Rocks